| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC SODIUM | 2147 |
| 1 | RITUXIMAB | 2139 |
| 2 | DICLOFENAC | 2105 |
| 3 | ADALIMUMAB | 2093 |
| 4 | LEFLUNOMIDE | 2063 |
| 5 | METHOTREXATE SODIUM | 2034 |
| 6 | PREDNISONE | 1989 |
| 7 | ACETAMINOPHEN | 1962 |
| 8 | TOCILIZUMAB | 1945 |
| 9 | CETIRIZINE HYDROCHLORIDE | 1943 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE BUTYRATE | 390 | 0.1974 |
| 1 | NEOMYCIN OINTMENT | 439 | 0.1790 |
| 2 | ASIAN GINSENG | 68 | 0.1611 |
| 3 | CAFFEINE CITRATE | 336 | 0.1440 |
| 4 | DICLOFENAC POTASSIUM | 1446 | 0.1308 |
| 5 | CORTISONE ACETATE | 1401 | 0.1121 |
| 6 | PSEUDOEPHEDRINE HCL | 1099 | 0.1004 |
| 7 | NAPROXEN SODIUM 220MG | 1298 | 0.0947 |
| 8 | DESOXIMETASONE | 1788 | 0.0928 |
| 9 | TRIPROLIDINE HYDROCHLORIDE | 18 | 0.0923 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2700 |
| 1 | Corticosteroid [EPC] | 2499 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2320 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 2179 |
| 4 | Vitamin C [EPC] | 2121 |
| 5 | Antirheumatic Agent [EPC] | 2063 |
| 6 | Vitamin B12 [EPC] | 2041 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 2012 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 1943 |
| 9 | Vitamin D [EPC] | 1929 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 210 | 0.1133 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 28 | 0.0370 |
| 2 | Provitamin D2 Compound [EPC] | 1028 | 0.0345 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 280 | 0.0321 |
| 4 | Antirheumatic Agent [EPC] | 2063 | 0.0195 |
| 5 | Aminosalicylate [EPC] | 1794 | 0.0178 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 2012 | 0.0145 |
| 7 | Interleukin-12 Antagonist [EPC] | 1461 | 0.0141 |
| 8 | Interleukin-23 Antagonist [EPC] | 1461 | 0.0140 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 1173 | 0.0139 |